(37) proposed that upregulation of TC2N represses the Phosphoinositide 3-kinases/serine-threonine kinase (PI3K/AKT) signaling pathway, which is typically constitutively active in some human cancers (110, 111). The gene discussed is AKT1; the disease is cancer.